Well done 202020. The article you posted support that there will be a continuing demand for antivirals. In addition, there will also be a continual demand for replenishing antivirals purchased 6 years ago that is “out of date”.
Quote: CDC's Strategic National Stockpile (SNS) contains approximately: 39.7 million regimens of oseltamivir capsules (Tamiflu), 9,279 regimens of oral suspension oseltamivir, and 10.3 million regimens of zanamivir (Relenza).
39.7+9.3= 49 million Tamiflu : 10.3 million Relenza
83% Tamiflu : 17% Relenza
When will BTA shareholders wake up to the fact the incompetence of the BTA management. Instead of demanding GSK pull up its sock to produce and market Relenza with best effort, your idiot CEO justified GSK’s performance by creating doubt about the demand for antivirals.
Well done 202020. The article you posted support that there will...
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)